about
Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's diseaseNeuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent PerspectivesThe Role of Autophagy, Mitophagy and Lysosomal Functions in Modulating Bioenergetics and Survival in the Context of Redox and Proteotoxic Damage: Implications for Neurodegenerative DiseasesDegeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's DiseaseThe role of the LRRK2 gene in ParkinsonismPossible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disordersSalvianolic acid B attenuates toxin-induced neuronal damage via Nrf2-dependent glial cells-mediated protective activity in Parkinson's disease modelsProtein-L-isoaspartate (D-aspartate) O-methyltransferase protects cardiomyocytes against hypoxia induced apoptosis through inhibiting proapoptotic kinase Mst114-3-3theta protects against neurotoxicity in a cellular Parkinson's disease model through inhibition of the apoptotic factor BaxThe TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.Untangling the Roles of Anti-Apoptosis in Regulating Programmed Cell Death using Humanized Yeast Cells.Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death.Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection.Endogenous repair by the activation of cell survival signalling cascades during the early stages of rat Parkinsonism.RTCB-1 mediates neuroprotection via XBP-1 mRNA splicing in the unfolded protein response pathway.Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of ratsPrevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolismEmerging neurotoxic mechanisms in environmental factors-induced neurodegeneration.Molecular cloning, epigenetic regulation, and functional characterization of Prkd1 gene promoter in dopaminergic cell culture models of Parkinson's disease.Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial.Presence of proNGF-sortilin signaling complex in nigral dopamine neurons and its variation in relation to aging, lactacystin and 6-OHDA insults.Directed differentiation of postnatal hippocampal neural stem cells generates nuclear receptor related‑1 protein‑ and tyrosine hydroxylase‑expressing cellsPathogenesis-targeted, disease-modifying therapies in Parkinson disease.Oxidative stress in genetic mouse models of Parkinson's disease.The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update.How close are we to individualized medicine for Parkinson's disease?mTOR Signaling in Parkinson's Disease.Alterations in bioenergetic function induced by Parkinson's disease mimetic compounds: lack of correlation with superoxide generation.A mechanistic study of proteasome inhibition-induced iron misregulation in dopamine neuron degeneration.Optimized quantities of GDNF overexpressed by engineered astrocytes are critical for protection of neuroblastoma cells against 6-OHDA toxicity.Biotransformed blueberry juice protects neurons from hydrogen peroxide-induced oxidative stress and mitogen-activated protein kinase pathway alterations.Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line.Beneficial Effect of Vitamin E in Rotenone Induced Model of PD: Behavioural, Neurochemical and Biochemical Study.Neuroprotective effect of matrine on MPTP-induced Parkinson's disease and on Nrf2 expressionProteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.A perspective on neuronal cell death signaling and neurodegeneration.Brain-derived neurotrophic factor stimulates proliferation and differentiation of neural stem cells, possibly by triggering the Wnt/β-catenin signaling pathway.Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.Potential molecular mechanisms mediating the protective effects of tetrahydroxystilbene glucoside on MPP+-induced PC12 cell apoptosis.
P2860
Q24337079-AA5BFC75-E355-4662-9DFE-487E92F3CEA0Q26747508-6E615465-78D5-4DF7-BA73-F0A13D465EC2Q26750137-A7B4DDD8-65A3-4F7B-88DD-E6A30FB824DDQ26750370-A41E8642-9572-47AF-8AC8-B0564E30EBD1Q27023749-4C50CE62-0F93-4FD2-A879-1BCDA1D87E3AQ28386662-050BAB13-032B-4251-ADB6-F7B488E99458Q28540349-692FAC23-30F8-457B-B663-72C8FD6E5D20Q28569469-1BD1F36E-CDF5-4D26-B734-D926EB13964FQ28742388-8B21620D-FCF6-4268-B2FD-BC54FAEDBC14Q33896035-29590DFE-E42C-4D58-A513-078217F4B0AAQ34307532-2C9DD35E-E96E-47ED-A89C-EF33F0996717Q34412601-F829E484-1D00-4726-902C-16C629240CF3Q34460675-F95BAAA1-47F4-4E85-8CF6-80120ACFCCB8Q34516390-632305A4-5090-46B1-A3BB-4E7414CE92E0Q34573419-7D31E909-E374-4FD3-A7BA-EC788CF13A12Q35065682-F9AED717-B876-4C26-94B9-2AF76B440ED9Q35554450-0FA8CC66-E0A7-48BA-96AA-B1FEAC6F1FB0Q35978121-D91CF3C4-4048-4424-B71B-1484945E780EQ36040875-355A8462-F3CA-4F0B-90BD-A432BAE37753Q36821650-B1C2CF36-C24B-40FF-961E-A12BD5B14683Q37022421-9A0232E3-B10C-4F5A-B6C4-03C639C88150Q37091907-2225D434-7B4F-41F4-B99C-D3428EBA29D7Q37190943-3CBBF0C2-901E-4EEF-B660-9C3538D60F0CQ37506492-418B99DD-447B-48B5-AAEB-DB5DFE665186Q38029327-3FE9F665-9B06-4D96-8E4F-AB9AF6995E16Q38331196-359F7487-6306-4C5A-BA5E-F44878EB6438Q38814888-B0924EA9-1970-4AC7-8475-4ADEB0328391Q38855225-06D11282-8E6A-48CC-AC6E-3156B527608BQ39329410-7FA5B80C-3A52-4D4D-B893-BA865CD4F0E9Q39407652-F1B7416B-A837-446C-A210-592C966100EDQ39463659-7A4A7A9D-118C-4EC1-A796-810C9E2FEF86Q39705220-4E6070E0-7478-4000-BEBC-8717B0EE6C06Q39795340-A0775689-9734-49CF-9170-CCCD4A09C923Q41884130-5019D6EC-E5D5-44EC-98F9-07E059EF14A2Q42329736-67DA659D-8414-4025-A9BF-F577DA95F6EDQ42962537-4248312D-7425-4219-98F7-06CB78095353Q43114776-5B1BE1B2-46C1-4A19-B0F2-D2D83A351674Q44195362-07E8E66A-6DDA-4B12-9F17-2265B77E3EB1Q45873810-D32413FF-5DB2-498D-8F88-CB81A18F728BQ46314664-5C34813B-2226-4D75-9234-8FF3F67ADFDA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targets for neuroprotection in Parkinson's disease
@en
Targets for neuroprotection in Parkinson's disease.
@nl
type
label
Targets for neuroprotection in Parkinson's disease
@en
Targets for neuroprotection in Parkinson's disease.
@nl
prefLabel
Targets for neuroprotection in Parkinson's disease
@en
Targets for neuroprotection in Parkinson's disease.
@nl
P2860
P1476
Targets for neuroprotection in Parkinson's disease
@en
P2093
David G Standaert
Talene A Yacoubian
P2860
P304
P356
10.1016/J.BBADIS.2008.09.009
P407
P577
2008-10-01T00:00:00Z